| |
As in so many other areas of clinical and biological research, the techniques
of recombinant DNA technology will increasingly be applied to the study
of mitochondria and their role in aging.
Already, animal models have been developed in which nuclear genes coding
for antioxidant enzymes active in mitochondria have been inactivated.
In one instance, mice lacking superoxide dismutase have been developed.
The animals show increased oxidant levels and a vulnerability to illnesses
similar to human neurodegenerative diseases. In fact, this animal model
was developed in order to study the relationship between oxidants and
neurodegenerative diseases. The animals are likely to serve as living
laboratories for the testing of new antioxidant and gene therapies that
reverse or neutralize oxidant damage.
Deliberate, targeted mutations have been introduced into mitochondrial
DNA for the purpose of observing the consequences. And nuclear DNA genes
that govern energy production in mitochondria have been genetically inactivated.
Furthermore, nuclear genes other than superoxide dismutase, which code
for proteins involved antioxidant activity, have been inactivated. Already,
some of these studies have yielded exciting results, since the mice so
treated developed heart defects that mimic human conditions. In a manner
similar to the models being developed for mitochondrial-associated neurodegenerative
disorders, these animals will provide a research model for investigating
the causes and potential remedies for certain diseases of aging, such
as cardiomyopathy.
If under-production of proteins and factors that detoxify oxygen free
radicals can have negative consequences, then it seems reasonable that
over-production of those same elements might, in some situations, prove
therapeutic. Evidence for this hypothesis has been developed by researchers
at the University of Guelph, Ontario, Canada in work with insects. They
have over-expressed a form of superoxide dismutase in nerve cells of the
fruit fly, Drosophila melanogaster. The normal lifespan of the flies went
up 40%. Moreover, a strain of flies from which SOD had been deleted, and
which died early as a result, could be rescued by introducing SOD into
their nuclear DNA.
If these results can be reproduced in higher animals, the day may come
when "boosting" antioxidant enzyme levels by gene splicing will
provide a means of neutralizing the increased oxidative stress that accompanies
aging. Researchers are also likely to build on early success of a non-DNA
approach to increasing antioxidants, in which such compounds are specifically
targeted to mitochondria.
With regard to the effects of diet on mitochondrial dysfunction and aging,
a study of rhesus monkeys on a restricted diet is ongoing. Results from
this important study are only now starting to appear. An intriguing observation
is that mitochondrial DNA from animals fed such a diet develop fewer problems,
particularly deletions, while they age, compared to their more richly
fed cousins. Scientists at the University of Wisconsin are planning to
observe the animals on a reduced calorie diet over an 8-year span. They
plan to take tissue samples periodically from these and control animals
and use DNA amplification techniques to measure the rate of deletions
in the animals as they age. Early data from the study have confirmed that
caloric restriction lowers oxidative damage in skeletal muscle.
The study of mitochondrial dysfunction and its relationship to aging
is still a relatively young area of investigation in biology. Mitochondria,
walled off by their double membrane, present obstacles to genetic and
other forms of manipulation. These problems are already being addressed,
and it is likely that the DNA and internal machinery of mitochondria will
one day be manipulated with ease. Mitochondrial decay is not likely to
be stopped anytime soon, but scientists appear confident that the process
can be slowed, and along with it, the process of aging and the development
of a number of age-related diseases.
|
 |